To assess whether FLT3 is a direct target of the LMO2 complex, we performed chromatin immunoprecipitation (ChIP)-seq in LMO2-expressing ETP-ALL PDX samples. This evidence concerns the gene LMO2 and acute lymphoblastic leukemia.